Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Evommune (EVMN) Accumulated Depreciation & Amortization (2024 - 2025)

Evommune (EVMN) has disclosed Accumulated Depreciation & Amortization for 2 consecutive years, with $600000.0 as the latest value for Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization rose 20.0% to $600000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $600000.0 through Dec 2025, up 20.0% year-over-year, with the annual reading at $600000.0 for FY2025, 20.0% up from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $600000.0 at Evommune, up from $500000.0 in the prior quarter.
  • The five-year high for Accumulated Depreciation & Amortization was $600000.0 in Q4 2025, with the low at $500000.0 in Q4 2024.